Abeona Therapeutics (ABEO) Return on Sales (2011 - 2026)

Abeona Therapeutics' Return on Sales history runs 15 years deep, the most recent figure standing at 0.02% for Q1 2026.

• In Q1 2026, Return on Sales changed N/A year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.06% (changed N/A YoY), while the FY2025 annual figure was 0.12%, changed N/A from the prior year.
• Return on Sales was 0.02% for Q1 2026 at Abeona Therapeutics, up from 0.04% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 3.11% in Q2 2025 to a low of 1.93% in Q4 2022.
• Historically, Return on Sales has averaged 0.14% across 5 years, with a median of 0.13% in 2023.
• Biggest YoY gain for Return on Sales was 179 bps in 2023; the steepest drop was 5 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 1.93% in 2022, then surged by 93 bps to 0.14% in 2023, then slipped by 7 bps to 0.14% in 2024, then surged by 74 bps to 0.04% in 2025, then soared by 48 bps to 0.02% in 2026.
• The last three Return on Sales figures came in at 0.02% (Q1 2026), 0.04% (Q4 2025), and 2.45% (Q3 2025), per Business Quant data.